UltraTech Cement to Purchase 26.18% Stake in Sunsure Solarpark

UltraTech Cement Limited announced on Wednesday, March 18, that it has signed an energy supply agreement along with a share subscription and shareholders’ agreement to acquire a 26.18% equity stake in Sunsure Solarpark Seven Private Limited.
Objective of Acquisition
The target company operates in the renewable energy sector, with a focus on power generation and transmission. In a regulatory filing, UltraTech stated that the investment aligns with its strategy to meet green energy needs, reduce energy costs, and adhere to captive power consumption norms under applicable electricity regulations.
The company plans to invest up to ₹19.2 crore in the transaction, to be settled in cash. The deal is expected to be completed within 180 days from the date of agreement execution.
Earlier, on March 6, UltraTech had disclosed a similar move—entering into agreements to acquire a 26.20% stake in Sunsure Solarpark Thirty Eight Private Limited, another renewable energy company engaged in power generation and transmission.
Also Read: NATCO Pharma to Consider Demerger of Agrochemical Business in Board Meet on March 24
UltraTech Q3FY26 Earnings Highlights
On the financial front, the cement major reported a consolidated net profit of ₹1,729.4 crore for Q3FY26, marking a 27% increase from ₹1,363 crore in the corresponding period last year.
Revenue for the quarter rose 23% year-on-year to ₹21,830 crore, compared to ₹17,778.8 crore previously. EBITDA grew 35.2% to ₹3,915 crore from ₹2,895.2 crore in Q3FY25.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Mar 19, 2026, 11:21 AM IST

Sachin Gupta
- Symbiotec Pharmalab Share Price Surges 20%; Signs Protein Manufacturing Deal with European Firm
- Lemon Tree Hotels Share Price in Focus Post Q2 FY27 Earnings Results: Total Income Up 18.1% YoY
- Ashoka Buildcon Share Price Falls Over 4% Post Q2 FY27 Earnings Results: Total Income Down 15.7% YoY
- Mphasis Share Price in Focus Post Q2 FY27 Earnings Results: Total Income Up 18.9% YoY
- DLF Share Price in Focus as It Forms Strategic Joint Venture with Everstone Group to Invest in IREO




